|
Y 10.11:2019-09
|
A summary of selected CBO reports on cash and accrual budgeting / |
1 |
|
Y 10.11:2020-01
|
A simplified model of how macroeconomic changes affect the federal budget / |
1 |
|
Y 10.11:2020-03
|
CBO's oil price forecasting record / |
1 |
|
Y 10.11:2020-04
|
Federal reinsurance for terrorism risk and its effects on the budget / |
1 |
|
Y 10.11:2020-05
|
Labor market effects of tax changes in times of high and low unemployment / |
1 |
|
Y 10.11:2020-06
|
CBO's projection of the effect of climate change on U.S. economic output / |
1 |
|
Y 10.11:2020-07
|
Key methods that CBO used to estimate the effects of pandemic-related legislation on output / |
1 |
|
Y 10.11:2020-08
|
How CBO analyzes the costs of proposals for single-payer health care systems that are based on Medicare's fee-for-service program's / |
1 |
|
Y 10.11:2020-09
|
The historical decline in real interest rates and its implications for CBO's projections / |
1 |
|
Y 10.11:2021-01
|
CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act / |
1 |
|
Y 10.11:2021-02
|
Estimating the legal status of foreign-born people / |
1 |
|
Y 10.11:2021-03
|
The economic effects of financing a large and permanent increase in government spending / |
1 |
|
Y 10.11:2021-04
|
Discrete choice models for estimating labor supply / |
1 |
|
Y 10.11:2021-05
|
Fair-value cost estimation and government cash flows / |
1 |
|
Y 10.11:2021-06
|
Revisiting the extent to which payroll taxes are passed through to employees / |
1 |
|
Y 10.11:2021-07
|
Governmental risk taking under market imperfections / |
1 |
|
Y 10.11:2021-08
|
Fair-value budgeting : practical issues / |
1 |
|
Y 10.11:2021-09
|
CBO's simulation model of new drug development / |
1 |
|
Y 10.11:2021-10
|
CBO's model and projections of U.S. international investment holdings and income flows / |
1 |
|
Y 10.11:2021-11
|
Distributional effects of reducing carbon dioxide emissions with a carbon tax / |
1 |
